Actionnariat et activité des initiés pour Annexon, Inc. (ANNX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $3.96 |
| Capitalisation | $648M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-10 | Blumenkranz Mark S. | A-Award | 175,000 | $943K |
| 2026-08-10 | Blumenkranz Mark S. | |||
| 2026-06-11 | Waddill William D. | A-Award | 65,000 | $306K |
| 2026-06-11 | Satter Muneer A | A-Award | 65,000 | $306K |
| 2026-06-11 | JONES WILLIAM A JR | A-Award | 65,000 | $306K |
| 2026-06-11 | Cockroft Bettina M. | A-Award | 65,000 | $306K |
| 2026-06-11 | Choi Jung | A-Award | 65,000 | $306K |
| 2026-06-11 | Carson William H. | A-Award | 65,000 | $306K |
| 2026-06-11 | Yednock Ted | M-Exempt | 30,646 | $57K |
| 2026-06-11 | Yednock Ted | M-Exempt | 30,646 | $57K |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $3.0M | $44.2M | $43.9M | $268.6M | $74.8M | $140.0M | $225.1M | $49.5M | $162.1M |
| Placements à Court Terme | 0 | 0 | 0 | $82.6M | $167.9M | $102.6M | $34.6M | $262.5M | $76.3M |
| Créances | $582000 | $225000 | $79000 | $3000 | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $4.9M | $45.7M | $45.4M | $354.0M | $247.7M | $248.1M | $263.9M | $316.5M | $242.2M |
| Immobilisations Corporelles | $2.8M | $2.3M | $2.1M | $1.9M | $38.2M | $36.0M | $32.8M | $29.3M | $25.8M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $7.8M | $48.1M | $49.9M | $355.9M | $287.0M | $285.1M | $297.7M | $350.1M | $277.6M |
| Dettes Fournisseurs | $1.5M | $1.3M | $2.4M | $3.7M | $11.2M | $7.4M | $5.5M | $10.4M | $14.9M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $2.9M | $3.3M | $4.9M | $10.6M | $21.7M | $22.4M | $17.9M | $30.5M | $42.6M |
| Dette à Long Terme | 0 | $107.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $54.0M | $10.3M | $6.4M | $11.7M | $55.1M | $53.9M | $47.1M | $57.0M | $65.9M |
| Réserves | -$47.1M | -$65.4M | -$102.6M | -$166.0M | -$296.3M | -$438.3M | -$572.5M | -$710.7M | -$917.4M |
| Capitaux Propres | -$46.2M | $37.9M | $43.5M | $344.3M | $231.9M | $231.2M | $250.6M | $293.1M | $211.6M |
| Dette Totale | $49.0M | $107.2M | 0 | 0 | $34.6M | $32.9M | $31.4M | $29.0M | $26.2M |
| Dette Nette | $46.0M | $63.0M | -$43.9M | -$351.2M | -$208.1M | -$209.8M | -$228.4M | -$283.0M | -$212.1M |
| Fonds de Roulement | $2.0M | $42.4M | $40.5M | $343.4M | $225.9M | $225.7M | $245.9M | $285.9M | $199.6M |
Santé financière
| Dette / Capitaux propres | 0.13 |
| Ratio de liquidité | 5.53 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 0.75 |
Rentabilité
| Rentabilité des capitaux propres | -106.15% |
| Rentabilité du capital investi | -99.93% |
| Rentabilité des actifs | -82.36% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ACIU · ALT · AURA · DBVT · DMAC · ENGN · KRRO
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ANNX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions